Westlake Chemical Partners (WLKP) Cash & Equivalents (2014 - 2026)

Westlake Chemical Partners has reported Cash & Equivalents for 13 years, with the latest figure at $44.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 10.75% year-over-year to $44.3 million; the trailing twelve-month figure through Mar 2026 stood at $44.3 million (down 10.75% YoY), and the FY2025 full-year result was $44.3 million, down 24.09% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $44.3 million, roughly flat from $44.3 million in the prior quarter.
• The five-year high for Cash & Equivalents was $104.6 million in Q1 2023, with the low at $18.4 million in Q2 2022.
• Historically, Cash & Equivalents has averaged $50.8 million across 5 years, with a median of $55.8 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents surged 443.77% — and 2024, when it plunged 46.69%.
• Westlake Chemical Partners' Cash & Equivalents stood at $64.8 million in 2022, then decreased by 9.51% to $58.6 million in 2023, then retreated by 0.52% to $58.3 million in 2024, then slipped by 24.09% to $44.3 million in 2025, then advanced by 0.05% to $44.3 million in 2026.
• The last three Cash & Equivalents figures came in at $44.3 million (Q1 2026), $44.3 million (Q4 2025), and $37.9 million (Q3 2025), per Business Quant data.